theheart.org

theheart.org cardiology aha 2010 acc 2011 esc 2011 aha 2011 tct 2011 tavi s yusuf revascularization acs clopidogrel slideshow presentation research highlights hrs 2011 fame ii diabetes theheart.org ppt advance everolimus-eluting stent sirolimus-eluting stent enoxaparin cardiac resynchronization europcr 2011 altitude partner cohort a acute coronary syndrome platelet inhibition atorvastatin myocardial infarction ffr renal denervation protect-af partner cohort b slides statins rivaroxaban warfarin emphasis-hf trial emphasis-hf study emphasis-hf pdf advance trial advance study advance pdf acc trial slideshow acute ischemic syndromes fondaparinux acc 2006 define gravitas cardiovascular risk tct 2007 act raft basket-prove closure i polyunsaturated fatty acids p-om3 spirit iv paclitaxel-eluting stents nyha shift acc 2008 aortic stenosis crt bare-metal stents coronary artery m leon g stone simvastatin heart failure lvef hypertension anglo-scandinavian discover flow base-acs discern-af prelude isar cabg precombat magellan oscar everest ii scientific sessions platinum rival aldosterone blockade emphasis-hf stemi acute myocardial infarction staccato xience v twente prasugrel trigger pci acute mi angioplasty heart disease type 2 diabetes heart attack stable cad aim-high fast power pallas tracer saturn romicat einstein pe cabg stampede ascert europcr 2012 atrial fibrillation compare ii comfortable-ami partner a omt af ablation heart rhythm society partner cohort b ppt transcatheter aortic-valve implantation placement of aortic transcatheter valve trial stich coronary artery disease stroke averroes apixaban clinical trial rocket af career achievement award adapt-des pfo closure live cases respect tct 2012 master trilogy-acs stemi-radial post ses partner b dessolve i and ii miami tavr pc trial munich trilogy acs gary. iabp shock ii woest esg 2012 the european society of cardiology defacto pure paramount esc 2012 congress access eu american heart association key trials aspire tact aha 2012 dal-outcomes pcsk9 poseidon / scipio phs ii trilogy acs/arctic umpire lodoco relax-ahf opera and forward thehear.org pcsk9 studies madit-rit aristotle study aristotle trial aristotle pdf dig pdf dig trial dig study comfortable-ami study comfortable-ami pdf comfortable-ami trial compare ii study compare ii trial compare ii pdf fame ii pdf fame ii trial fame ii study euraction pdf euraction trial euraction study tips 2 pdf tips 2 study tips 2 trial vcsqi pdf vcsqi study vcsqi trial cure-af pdf cure-af trial cure-af study raaft-2 study raaft-2 trial raaft-2 pdf acrin/pa pdf acrin/pa trial acrin/pa study ascert pdf ascert study ascert trial issue-3 trial issue-3 study issue-3 pdf einstein pe pdf einstein pe trial einstein pe study romicat ii trial romicat ii study romicat ii pdf tra 2ºp-timi 50 pdf tra 2ºp-timi 50 trial tra 2ºp-timi 50 study stampede trial stampede pdf stampede study tracer pdf tracer trial tracer study power trial power pdf power study fast study fast trial fast pdf c-port e trial c-port e study c-port e pdf mi freee pdf mi freee trial mi freee study pallas trial pallas pdf pallas study saturn pdf saturn trial saturn study elevate-timi 56 pdf elevate-timi 56 study elevate-timi 56 trial atlas acs atlas acs 2 trial atlas acs 2 study atlas acs 2 pdf trigger pci trial trigger pci study trigger pci pdf bridge study bridge pdf bridge trial thehert.org advise trial advise study advise pdf twente study twente trial twente pdf staccato trial staccato pdf staccato study prodigy trial prodigy pdf prodigy study corp pdf corp study corp trial examination trial examination study examination pdf hcs pdf hcs trial hcs study hcs theheart.org tct trial hrs trial europcr trial parreclose 2-acs dal-vessel pdf dal-vessel study dal-vessel trial ascot-lla pdf ascot-lla study ascot-lla trial discover flow trial discover flow pdf discover flow study care-hf trial care-hf study care-hf pdf current oasis-7 trial current oasis-7 study current oasis-7 pdf enhance trial enhance pdf enhance study extract-timi 25 trial extract-timi 25 pdf extract-timi 25 study accord lipid trial accord lipid study accord lipid pdf everest study everest trial everest pdf magellan pdf magellan study magellan trial oscar trial oscar study oscar pdf precombat study precombat trial precombat pdf platinum trial platinum pdf platinum study resolute us study resolute ac trial resolute ac study resolute us trial excellent pdf excellent trial excellent study isar cabg trial isar cabg study isar cabg pdf altitude study altitude trial altitude pdf prelude trial prelude study prelude pdf discern-af trial. discern-af study discern-af pdf partner trial cohort a partner cohort a stroke data study partner cohort a stroke data trial base-acs study base-acs trial base-acs pdf courage pdf courage trial courage study invest study invest trial invest pdf protect-af pdf protect-af study protect-af trial spirit iv trial spirit iv pdf spirit iv study triton-timi 38 trial triton-timi 38 study triton-timi 38 pdf ascend-hf pdf ascend-hf trial ascend-hf study symplicity symplicity htn-2 trial symplicity htn-2 study symplicity htn-2 pdf p-om3 pdf p-om3 study p-om3 trial closure i trial closure i study closure i pdf basket-prove pdf basket-prove study basket-prove trial raft trial raft study raft pdf ascot-crp pdf ascot-crp study ascot-crp trial partner cohort a trial elderly patients partner cohort a study partner cohort a pdf act trial act study act pdf rival study rival pdf rival trial horizons ami study horizons ami pdf horizons ami trial prove-it pdf prove-it trial prove-it study scd-heft trial scd-heft study scd-heft pdf synergy trial synergy study synergy pdf accord glucose trial accord glucose study accord glucose pdf accord bp trial accord bp pdf accord bp study gravitas trial gravitas study gravitas pdf pure study pure trial pure pdf acuity trial acuity study acuity pdf allhat study allhat trial allhat pdf hope pdf hope study hope trial athena trial athena pdf athena study acc research acc study ideal study ideal trial ideal pdf madit-crt study madit-crt trial oasis-5 study oasis-5 trial ontarget trial ontarget pdf ontarget study everest ii trial everest ii study edge-to-edge repair study everest ii pdf research esc esc trial tct pdf research tct research aha pdf champion trial ppt champion trial pdf champion study champion trial ascend hf symplicity htn ascot crp qrs emphasis-hf horizons-ami sort-out 4 partner compare cap isar-test 4 zilver ptx biofreedom tct 2010 robotically assisted pci copps lesson 1 cure/active a star-heart atoll einstein dvt innovate pci plato genetic substudies response futura oasis-8 alpha omega trial endovascular valve surgery mitraclip aha 2009 champion–pci champion–platform d bhatt angiotensin ontarget ramipril global endpoint ongoing telmisartan receptor blocker oasis-5 factor-xa esc 2005 antithrombotic drugs oasis-6 safe antithrombotic agent ventricular dyssynchrony multicenter automatic defibrillator ideal lipid lowering t pedersen aha 2005 esc 1999 vascular disease heart outcomes prevention evaluation vessel revascularization endeavor zotarolimus taxus stents high-risk arterial fibrillation hrs 2008 sh hohnloser athena moderate risk arterial fibrillation chlothalidone antihypertensive lipid lowering treatment percutaneous revasculation acute catheterization and urgent intervention tria surgical revasculation high-risk acs gw stone prospective urban rural epidemiology chronic noncommunicable diseases societal influences cv risk factors left ventricular assist device mechanical assisted circulatory support interagency registry k d aaronsonm heartware thoratec's heartmate ii anacetrapib cetp cetp inhibition c cannon cholesteryl ester ldl-cholesterol residual platelet reactivity m price platelet-function tests thrombosis verifynow assay acc 2010 accord bp w c cushman blood–pressure-lowering arm glucose-lowering arm accord glucose synergy acc 2004 glycoprotein k mahaffey esc 2008 kk teo ace-intolerant high-risk diabetes transcend cardiovascular disease angiotensin-receptor blockers nyha class 2-3 g bardy scd-heft cardiac death amiodarone total cholesterol cp cannon prove-it pravastatin acc2004 stents in acute myocardial infarction horizons ami unfractionated heparin nyha class 2–4 omega-3 fatty acids miocardico–heart failure chronic heart failure statin therapy gissi–hf coronary intervention radial access s jolly acute coronary syndromes femoral access o berwanger antioxidant n-acetylcysteine acetylcysteine contrast-induced nephropathy c miller stroke data transcatheter aortic-valve aats 2011 c-reactive protein ascot-crp ps sever implantable cardioverter-defibrillator ambulatory heart failure moderate hf a tang resynchronization pharmacological therapy c kaiser bare-metal cobalt-chromium stent basel stent cost-effectiveness trial basket-late drug-eluting stents starflex septal closure patent foramen ovale paradoxical embolism transient ischemic attack a furlan omega-3 pufa pr kowey renal sympathetic md esler symplicity htn-2 uncontrolled hypertension clinical effectiveness decompensated heart failure nesiritide ascend-hf r califf s wiviott triton-timi 38 aha 2007 prasugrel-thrombolysis target lesion failure everolimus-eluting stents cad tct 2009 inhibitor ivabradine ivabradine m komajda systolic heart sodium-potassium esc 2010 sinoatrial node ventricular dysfunction resynchronization reverses remodeling reverse c linde acc 2009 embolic protection dr holmes warfarin therapy probe c pepine acc 2003 international verapamil sr-trandolapril invest acc 2007 w e boden clinical outcomes aggressive drug evaluation courage pci p karjalainen major adverse cardiovascular events mace bio-active-stent patient diaries implantable loop recorder a verma c napolitano programmed electrical stimulation brugada syndrome icd implanted devices shock therapy mortality b powell grafts j mehilli drug-eluting stenting hc gwon xience v/promus excellent cypher select zotarolimus-eluting resolute ac p serruys resolute us novo lesions promus element novo coronary artery lesions platinum scaffolding sj park cabg surgery olmesartan calcium-channel blocker. h ogawa calcium antagonists a cohen inflammatory/rheumatic diseases ischemic stroke active cancer vte prophylaxis everest mitraclip vs surgery mitral regurgitation t feldman endovascular valve edge-to-edge repair accord lipid lipid-lowering arm h ginsberg blood lipids cardiovascular risk in diabetes extract–timi 25 thrombolysis low-molecular-weight heparin thrombolysis reperfusion myocardial infarction 25 heterozygous familial hypercholesterolemia atherosclerotic ezetimibe enhance clopidogrel optimal s mehta current oasis-7 antiplatelet strategy esc 2009 nyha class 3-4 hf care-hf qrs jgf cleland f zannad perindopril macrovascular outcomes indapamide microvascular outcomes type 2 diabetes mellitus invasively measured fractional flow reserve stenoses ffrct bon-kwon koo noninvasive fractional flow reserve ascot-bpla coronary heart disease lipid lowering arm p sever ascot-lla chd cetp inhibitor dalcetrpib t luscher dal-vessel endothelial function source scaar registry des meta-analysis subcutaneous-lead icd vt ablation study efs confirm working with industry raft. aeds hrs/ehra consensus statement partner cohort b cost analysis new orleans excellent. resolute tct 2011 keynote address bridge advise (ffr) partner a (qol and efficacy) tct 2011 career achievement award rifle steacs partner b san francisco homburg cream & sugar study cv morbidity cv mortality glucose tolerance tg tolerance u laufs hcs mild hf b pitt high-risk subgroups eplerenone xience v stent everolimus drug-eluting stent bare-metal stent cobalt-chromium stent primary pci corp colchicine for recurrent pericarditis m imazio mvalgimigli dual antiplatelet therapy intimal hyperplasia prodigy drug-eluting-sent implantation aortic-valce replacement survery l thuesen valvular aortic stenosis endeavor resolute target vessel failure drug-eluting stent c von birgelen nace st elevation transradial transfemoral femoral steacs primary angioplasty radia fractional flow reserve adenosine vasodilator j davies thienopyridines ticlopidine d angiolillo coronary stents undergoing surgery cangrelor platelet reactivity d trenk elective stent placement adverse cv coronary drug-eluting sents statin drug vitamin niacin cholesterol w boden vascular events. m gibswon atlas acs 2 j mega elevate-timi 56 thrombolysis in mi 56 escalating clopidogrel cyp2c19 allele coronary atherosclerosis rosuvastatin intravascular ultrasound s nicholls coronary atheroma cv events permanent af sj connolly permanent atrial fibrillation dronedarone post-myocardial infarction n choudhry mi freee full perscription drug arbs aceis free rx event economic evaluation beta blockers ahc 2011 t aversano c-port e cardiovascular patient outcomes research team elec open-heart surgery backup surgical ablation treatment atrial fibrillation catheter ablation lucas boersma af treatment lj appel practice-based opportunities for weight reduction obese people weight loss preventing mi preventing stroke vopaxar advanced medical therapy bariatric surgery strock vorapaxar thrombin receptor antagonist tra 2ºp-timi 50 atherothrombotic ischemic atherosclesis computer assisted tomography ii symptomatic pulmonary embolism acute symptomatic pulmonary embolism symptomatic dvt oral rivaroxaban syncope of uncertain etiology pacemaker therapy systolic neurally mediated syncope issue-3 accf sts coronary disease traditional care emergency department ccta acrin/pa raaft-2 ntiarrhythmic drug aad paroxysmal recurrent af catheter-based pulmonary vein isolation af irrigated unipolar rf ablation cure-af concomitant cardiac surgery biopolar rf ablation atrioventricular nodal cardioblate postoperative product transfusion transfusion guidelines blood-product use postoperative events cardiac operations. intraoperative product transfu ldl-c high-risk primary-prevention bp two doses of low-strength polycap low-strength polycap tips 2 physical-activity patterns cardiac rehabilitation program euraction partners spouses diet pci plus omt ffr-guided nhbli freee elevate adopt aha 2011 s af c-port e atlas c-porte e acrin pa coronary issue 3 tra 2°p – timi 50 mendelian rct acc 2012 nobori biolimus-eluting stent everolimus eluting biolimus a9 eluting stent p smits biomatrix l räber gazelle in stemi biolimus-eluting stent acute st-elevation myocardial infarction total mortality left ventricular ejection fractions m gheorghiade heart failure congress 2012 clinical heart failure sinus rhythm digitalis investigation group digoxin dig systemic embolism aristotle c granger prevent stroke live demonstrations nobori biolimus stent everolimus stents martin leon bioerodable polymer des source xt reimbursement live demonstrations; compare ii; nobori biolimus s ethica award 2012 simplicity htn 2 surgical valve failure vivek y reddy carlos morillo raaft 2 hrs starter magnasafe wpw douglas zipes catheter ablation michel haϊssaguerre watchman laa closure device dan roden firm ablation riata raed abdelhadi debra doud icd lead safety confusion memory loss fda statin survey blood glucose esc cardiology conference esc cardiology news esc medical congress esc slides esc paris european society of cardiology stitch slides stitch ppt averroes trial slides averroes ppt re-ly trial slides re-ly ppt plato trial slides plato ppt rocket ppt trial slides rocket af ppt partner cohort b trial jupiter ppt jupiter slides severe aortic disease cost analysis partner cohort b studies surgical treatment for ischemic heart failure apixaban versus acetylsalicylic acid to prevent st aspirin randomized evaluation of long-term anticoagulant t re-ly venous thromboembolism dabigatran warfarin alternative theheart ppt oral anticoagulants thromboembolism jupiter trial trial rosuvastatin platelet plato thienopyridine ticagrelor non-valvular af stroke prevention theheartorg ppt aortic transcatheter valve trial partner cohort b aortic trial